Home › Funds › Frazier Life Sciences Management, L.P. › MBX

Frazier Life Sciences Management, L.P. position in MBX

MBX BIOSCIENCES INC COM · Health Care

Frazier Life Sciences Management, L.P. reported holding 6,652,013 shares of MBX (MBX BIOSCIENCES INC COM) in its Q2 2026 13F filing — a position valued at US$367.2M, representing 8.00% of its reported portfolio and ranking #4 among its reported holdings. Frazier Life Sciences Management, L.P. has disclosed MBX holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)6.65M sh
Reported value held$367.19M
Portfolio Weight8.00%
First reportedQ3 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Frazier Life Sciences Management, L.P.'s MBX position evolved

Frazier Life Sciences Management, L.P. first disclosed a stake in MBX in Q3 2024 at 5,985,347 shares (US$155.5M). The position peaked in Q2 2026 at 6,652,013 shares, worth US$367.2M. Across 8 filings, Frazier Life Sciences Management, L.P. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 6,652,013 shares valued at US$367.2M.

Quarter by quarter

QuarterSharesValueChange
Q3 2024 5.99M $155.50M New
Q4 2024 5.99M $110.31M Hold
Q1 2025 5.99M $44.17M Hold
Q2 2025 5.99M $68.29M Hold
Q3 2025 6.65M $116.41M Add
Q4 2025 6.65M $209.80M Hold
Q1 2026 6.65M $198.56M Hold
Q2 2026 6.65M $367.19M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MBX and 13F data

MBX (MBX BIOSCIENCES INC COM) is a Health Care company. 73 other funds we track also report a position in MBX — the largest reported positions include NEA Management Company, LLC (US$199.5M), ORBIMED ADVISORS LLC (US$189.3M), Paradigm Biocapital Advisors LP (US$138.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MBX

All MBX fund holders →

FAQ

How long has Frazier Life Sciences Management, L.P. held MBX?

Frazier Life Sciences Management, L.P. has disclosed MBX holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is Frazier Life Sciences Management, L.P.'s current position in MBX?

As of Q2 2026, Frazier Life Sciences Management, L.P. holds 6.65M shares of MBX (MBX BIOSCIENCES INC COM), valued at $367.19M, representing 8.00% of its reported portfolio and ranking #4.

Has Frazier Life Sciences Management, L.P. been buying or selling MBX?

In the latest 13F filing (Q2 2026), Frazier Life Sciences Management, L.P. held unchanged its position in MBX. The position peaked in Q2 2026 at 6.65M shares.

Which other funds hold MBX?

Other major institutional holders of MBX include NEA Management Company, LLC, ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.